Specific Aim:
The specific aim of this education and outreach component is to educate clinicians and basicscience researchers about bioterrorism and emerging infectious diseases and provide a common body ofknowledge to serve as a bridge to foster collaboration, formulate new ideas on project direction, and to stimulateinterest in other clinicians and researchers at those institutions participating in the RCE.Objectives, design and methods: At many institutions, there is little opportunity or encouragement for scientificexchange of ideas relating to bioterrorism or emerging infectious diseases. Providing a common educationalbase for both basic scientists and clinicians may provide opportunities to think about bioterrorism from anotherangle, foster discussion with colleagues, and generate new ideas for bench research or clinical investigation. Inthe process of allowing scientific exchange of information, new relationships will be formed that might be useful inthe event that the RCE laboratories or clinical facilities were utilized in an emergency.Two types of training are proposed as part of the RCE education and outreach project: 1) basic infectious agenthandling training for all laboratory workers affiliated with the RCE, including training in biosafety, biocontainment,infection control, and hazardous wastes, and 2) annual, regional, comprehensive bioterrorism and emerginginfections training incorporating both clinical and basic science components.1. Basic Infectious Agent Handling Training All affiliated laboratory workers of the RCE will be requiredto have training in biosafety, biocontainment, infection control, and biohazardous waste disposal. Laboratoryworkers affiliated with the RCE that do not have access to training at their University site (and do not havedocumentation of completion of these components) will be trained via web-based modules, developed by Dr.Robert Ellis, the Biosafety officer of the RCE. There will be an assessment of understanding of the coreconcepts presented that will be completed by the laboratory worker.2. Annual Bioterrorism and Emerging Infections Training Annual 1-1/2 day training programs will begiven at 4 geographic nodes of the RCE: Denver (University of Colorado Health Science Center/TheChildren's Hospital/Denver Health), Fort Collins, CO (Colorado State University/CDC/University of Wyoming),Salt Lake City, (University of Utah) and Bozeman, MT (Montana State University/University of Montana).North and South Dakota participants could register for any of these sites. These training workshops are opento RCE laboratory researchers and personnel, clinicians, and on space-available basis to other researchers,physicians, nurses, and veterinarians at the affiliated RCE sites. Time will be allotted for discussion andinteraction between clinical and basic science researchers to foster collaboration, stimulate scientific inquiry,and to allow participants in the RCE to become acquainted with their colleagues and areas of expertise.These relationships will be advantageous in the event of a natural or accidental biologic event in which theRCE is utilized to provide surge capacity to existing healthcare or laboratory systems. Prior to the training(pretest) and at the end of each training program (post-test), participants will complete a short assessment oftheir understanding of the core concepts described in the learning objectives. The results of theseassessments will be used to evaluate teaching methods and to plan future training. PowerPoint presentationsof the training session lectures will be published on the internet for access by RCE personnel who were notable to attend.This project provides education for basic laboratory researchers in biosafety, infection control principles,biocontainment, and biohazardous waste disposal that should be core knowledge for individuals working withbiologic agents. More importantly, the Bioterrorism/Emerging Infections training program provides a mechanismto deliver a common body of knowledge to both clinicians and basic scientists, allows an avenue forcommunication, and serves as a forum to establish important regional relationships among colleagues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AI065357-04
Application #
7641016
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-05-01
Project End
2009-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
4
Fiscal Year
2008
Total Cost
$201,118
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Type
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Webb, Jessica R; Price, Erin P; Somprasong, Nawarat et al. (2018) Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei. Future Microbiol 13:1403-1418
York, Joanne; Nunberg, Jack H (2018) A Cell-Cell Fusion Assay to Assess Arenavirus Envelope Glycoprotein Membrane-Fusion Activity. Methods Mol Biol 1604:157-167
Rhodes, Katherine A; Somprasong, Nawarat; Podnecky, Nicole L et al. (2018) Molecular determinants of Burkholderia pseudomallei BpeEF-OprC efflux pump expression. Microbiology 164:1156-1167
Pettey, W B P; Carter, M E; Toth, D J A et al. (2017) Constructing Ebola transmission chains from West Africa and estimating model parameters using internet sources. Epidemiol Infect 145:1993-2002
Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463
Skyberg, Jerod A; Lacey, Carolyn A (2017) Hematopoietic MyD88 and IL-18 are essential for IFN-?-dependent restriction of type A Francisella tularensis infection. J Leukoc Biol 102:1441-1450
Plumley, Brooke A; Martin, Kevin H; Borlee, Grace I et al. (2017) Thermoregulation of Biofilm Formation in Burkholderia pseudomallei Is Disrupted by Mutation of a Putative Diguanylate Cyclase. J Bacteriol 199:
Randall, Linnell B; Georgi, Enrico; Genzel, Gelimer H et al. (2017) Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance. J Antimicrob Chemother 72:1258-1260
Podnecky, Nicole L; Rhodes, Katherine A; Mima, Takehiko et al. (2017) Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm. MBio 8:
Cummings, Jason E; Slayden, Richard A (2017) Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response. PLoS Negl Trop Dis 11:e0005209

Showing the most recent 10 out of 258 publications